Evelo Biosciences Announces Submission of IND for a Phase 2 Study of EDP1815 in COVID-19 Patients May 7, 2020 at 8:30 AM EDT Click here for webcast Supporting Materials Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital Announce Submission of IND for a Phase 2 Study of EDP1815 in COVID-19 Patients 59.1 KB Phase 2 Study of Early Intervention with EDP1815 for Patients with COVID-19 462.7 KB
Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital Announce Submission of IND for a Phase 2 Study of EDP1815 in COVID-19 Patients 59.1 KB